Radiopharm Theranostics Ltd (RADX) Other Non-Current Liabilities (2023)
Radiopharm Theranostics (RADX) posted quarterly Other Non-Current Liabilities of $169202.0 for Q2 2023.
Radiopharm Theranostics Ltd (RADX) Other Non-Current Liabilities (2023) Analysis & Trends
Radiopharm Theranostics (RADX) has reported Other Non-Current Liabilities for 1 consecutive years, with $169202.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Other Non-Current Liabilities changed N/A year-over-year to $169202.0; the TTM figure through Jun 2023 stood at $169202.0 (changed N/A YoY), while the FY2023 annual figure was $169202.0, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $169202.0 in Q2 2023 per RADX's latest filing.
- Across five years, Other Non-Current Liabilities topped out at $169202.0 in Q2 2023 and bottomed at $169202.0 in Q2 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 169,202.00 |